Cellectar Biosciences, Inc.
CLRB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $11 | $15 | $14 |
| - Cash | $13 | $11 | $14 | $23 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $1 | -$9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$6 | -$6 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$5 | -$7 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.41 | -3.39 | -4.3 | -1.68 |
| % Growth | 58.4% | 21.2% | -155.9% | – |
| Operating Cash Flow | -$4 | -$5 | -$9 | -$11 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$4 | -$5 | -$9 | -$11 |